Immunological and virological findings in a patient with exceptional post-treatment control: a case report

被引:0
|
作者
Climent, Nuria [1 ,2 ]
Ambrosioni, Juan [1 ,2 ]
Gonzalez, Tania [1 ]
Xufre, Cristina [1 ]
Casadella, Maria [3 ]
Noguera-Julian, Marc [2 ,3 ,4 ]
Paredes, Roger [2 ,3 ,4 ]
Plana, Montserrat [1 ]
Grau-Exposito, Judith [1 ]
Mallolas, Josep [1 ,2 ]
Alcami, Jose [1 ,5 ]
Sanchez-Palomino, Sonsoles [1 ,2 ]
Miro, Jose M. [1 ,2 ]
机构
[1] Univ Barcelona, Hosp Clin IDIBAPS, HIV Unit, Barcelona 8036, Spain
[2] CIBER Infect Dis CIBERINFEC, Madrid, Spain
[3] Hosp Univ Germans Trias i Pujol, IrsiCaixa AIDS Res Inst, Badalona, Spain
[4] Univ Vic, Cent Univ Catalonia, Vic, Catalonia, Spain
[5] Inst Salud Carlos III, Madrid, Spain
来源
LANCET HIV | 2023年 / 10卷 / 01期
关键词
HIV-1; INFECTION; RECEPTOR; CELLS; SUSCEPTIBILITY; INFANTS;
D O I
10.1016/S2352-3018(22)00310-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain viral loads below detection limits without ART, constituting a realistic model for long-term HIV remission. Here, we describe the HIV control mechanisms of an individual who showed exceptional post-treatment control for longer than 15 years.Methods We report the case of a Hispanic woman aged 59 years with sexually acquired acute HIV infection, who was included in an immune-mediated primary HIV infection trial involving a short course of ciclosporine A, interleukin-2, granulocyte macrophage colony-stimulating factor, and pegylated interferon alfa, followed by analytical treatment interruption. We did the following viral assays: total and integrated HIV-1 DNA in CD4 T cells and rectal tissue, quantitative viral outgrowth assay, HIV-1 infectivity in peripheral blood mononuclear cells and CD4 T-cell cultures and viral inhibitory activity by natural killer (NK) and CD8 T cells. NK and T-cell phenotypes were determined by flow cytometry. HLA, killer cell immunoglobulin-like receptors, Delta 32CCR5, and NKG2C alleles were genotyped.Findings After ART and immunomodulatory treatment, the person maintained undetectable plasma viral load for 15 years. HIV-1 subtype was CFR_02AG, CCR5-tropic. We found progressive reductions in viral reservoir during the 15-year treatment interruption: total HIV DNA (from 4573middot50 copies per 106 CD4 T cells to 95middot33 copies per 106 CD4 T cells) and integrated DNA (from 85middot37 copies per 106 CD4 T cells to 5middot25 copies per 106 CD4 T cells). Viral inhibition assays showed strong inhibition of in vitro HIV replication in co-cultures of CD4 T cells with autologous NK or CD8 T cells at 1:2 ratio (75% and 62%, respectively). Co-cultures with NK and CD8 T cells resulted in 93% inhibition. We detected higher-than-reference levels of both NKG2C-memory-like NK cells (46middot2%) and NKG2C gamma delta T cells (64middot9%) associated with HIV-1 control.Interpretation We described long-term remission in a woman aged 59 years who was treated during primary HIV infection and has maintained undetectable viral load for 15 years without ART. Replication-competent HIV-1 was isolated. NKG2C-memory-like NK cells and gamma delta T cells were associated with the control viral replication. Strategies promoting these cells could bring about long-term HIV remission. Funding Fondo Europeo para el Desarrollo Regional (FEDER), SPANISH AIDS Research Network (RIS), Fondo de Investigacion Sanitaria (FIS), HIVACAT, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), CERCA Programme/Generalitat de Catalunya, la Caixa Foundation, and Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC). Copyright (c) 2022 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E42 / E51
页数:10
相关论文
共 50 条
  • [31] DESIGNING FOR EFFECTIVE POST-TREATMENT, PATIENT COMFORT AND CARE
    Ramos, Rachel Sax
    Song, David
    Razdan, Chaitenya
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [32] Musculoskeletal Sarcoma: Update on Imaging of the Post-treatment Patient
    Garner, Hillary W.
    Kransdorf, Mark J.
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2016, 67 (01): : 12 - 20
  • [33] Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion
    Lee, KM
    Cho, SW
    Kim, SW
    Kim, HJ
    Hahm, KB
    Kim, JH
    JOURNAL OF VIRAL HEPATITIS, 2002, 9 (03) : 208 - 212
  • [34] Radiation-induced gliosarcoma post-treatment for a recurrent pituitary adenoma: A case report
    Davuluri, Venkata Shashank
    Balasubramanian, Archana
    Kanagavel, M. Yathwin
    D'Cruze, Lawrence
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2023, 34
  • [35] Importance of differential diagnosis post-treatment of adenocarcinoma of the uterine cervix: a case report of sarcoidosis
    Oliveira Calil de Paula, S.
    de Assis Brito Alves, M. C.
    de Almeida Falcao Junior, J. O.
    Soares Laranjeira, C. L.
    Salvador Geo, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (05) : 714 - 716
  • [36] Clinical, Virological, and Immunological Findings in Patients with Toscana Neuroinvasive Disease in Croatia: Report of Three Cases
    Vilibic-Cavlek, Tatjana
    Zidovec-Lepej, Snjezana
    Ledina, Dragan
    Knezevic, Samira
    Savic, Vladimir
    Tabain, Irena
    Ivic, Ivo
    Slavuljica, Irena
    Bogdanic, Maja
    Grgic, Ivana
    Gorenec, Lana
    Stevanovic, Vladimir
    Barbic, Ljubo
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2020, 5 (03)
  • [37] DEVELOPMENT OF VIROLOGICAL BREAKTHROUGH IN TREATMENT NAIVE HEPATITIS B PATIENT RECEIVING TENOFOVIR: A CASE REPORT
    Prasetya, Ignatius Bima
    Lugito, Nata Pratama Hardjo
    Kurniawan, Andree
    GUT, 2020, 69 : A85 - A85
  • [38] PRE- AND POST-TREATMENT COMPUTED TOMOGRAPHIC FINDINGS OF A PRIMARY INTRANASAL TRANSMISSIBLE VENEREAL TUMOR IN A CANINE PATIENT
    Patsikas, M.
    Adamama-Moraitou, K.
    Thomas, A.
    Soultani, C.
    Chrissogonidis, I.
    Fotiadou, A.
    Trikoupi, G.
    Papadopoulou, P.
    Ilia, G.
    Kosmas, P.
    Farmakis, P.
    Ilia, T.
    Kritsepi, M.
    Pardali, D.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 571 - 576
  • [39] Hope of post-treatment control after perinatal infection?
    Rabie, Helena
    Cotton, Mark F.
    LANCET HIV, 2016, 3 (01): : E6 - E8
  • [40] MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings
    Dutoit J.C.
    Verstraete K.L.
    Insights into Imaging, 2016, 7 (4) : 553 - 569